Abstract
Apoptotic protease activating factor 1 (Apaf-1) has long been characterized as a scaffold protein essential for assembling the "apoptosome"—a caspase activation platform—following its interaction with cytochrome c. However, despite its structural similarity to animal NOD-like receptors (NLRs) and plant resistance (R) proteins, its role in innate immunity remained elusive. This study identifies Apaf-1 as an evolutionarily conserved DNA sensor across species, including lancelets, fruit flies, mice, and humans. Upon recognizing cytoplasmic DNA, mammalian Apaf-1 recruits receptor-interacting protein 2 (RIP2) via its WD40 repeat domain, initiating NF-κB-driven inflammation. Crucially, DNA binding competes with cytochrome c for Apaf-1, acting as a molecular checkpoint that determines whether a cell undergoes apoptosis or initiates an inflammatory response.
Bridging the Evolutionary Gap in DNA Sensing
The innate immune system relies on detecting misplaced molecules, such as viral DNA in the cytoplasm, to trigger defense mechanisms. While the cGAS-STING pathway is the primary DNA-sensing mechanism in mammals, its evolutionary precursors in many invertebrates lack DNA-binding capabilities. This research sought a more primordial, universal DNA sensor by examining the lancelet (Branchiostoma belcheri), an evolutionary bridge between invertebrates and vertebrates.
Methods and Discovery
To identify novel DNA-binding proteins, researchers performed proteomic screening by incubating cytosolic extracts from lancelet cells with biotinylated DNA-coated beads. This "fishing" expedition identified a lancelet Apaf-1 homolog (BbeApaf-J) as a primary DNA binder.
To validate these findings in mammals, the team employed:
- Biochemical Characterization: Surface Plasmon Resonance (SPR) and Electrophoretic Mobility Shift Assays (EMSA) were used to measure the binding affinity between human/mouse Apaf-1 and double-stranded DNA (dsDNA).
- Genetic Models: CRISPR-Cas9 was used to generate Apaf-1 knockout (KO) cell lines (HeLa, A549, MEFs) to test immune responses independently of the cGAS-STING pathway.
- In Vivo Studies: Apaf-1 heterozygous knockout mice were challenged with DNA viruses (HSV-1 and Vaccinia virus) to assess physiological survival and systemic inflammation.
Key Insights: The Dual Identity of Apaf-1
1. A Molecular Tug-of-War
Apaf-1 exhibits a "secret life" as a DNA sensor. Traditionally, it binds cytochrome c to trigger apoptosis. However, structural modeling and biochemical assays reveal that dsDNA and cytochrome c compete for the same general regulatory region on Apaf-1. If dsDNA binds first, it physically occludes cytochrome c, effectively blocking the apoptotic pathway and switching the cell's fate toward inflammation.
2. The RIP2 Signaling Axis
Unlike its apoptotic role, where it recruits Caspase-9, the inflammatory role of Apaf-1 involves the recruitment of the adaptor protein RIP2 (RIPK2). This recruitment occurs via the WD40 repeat domain of Apaf-1 and promotes RIP2 oligomerization, which subsequently activates the NF-κB pathway to produce inflammatory cytokines.
Key Results and Physiological Significance
- High-Affinity DNA Binding: Human and mouse Apaf-1 bind dsDNA with high affinity, with dissociation constants ($K_d$) in the low nanomolar range (e.g., $1.71 \times 10^{-7}$ M for hApaf-1 + HSV60).
- cGAS-Independent Inflammation: In A549 cells (which are cGAS-competent), the loss of Apaf-1 significantly impaired the induction of inflammatory markers like CXCL1 and IL-6 following viral infection, demonstrating that Apaf-1 is a critical, independent component of the DNA-sensing machinery.
- Survival in Vivo: The physiological importance was underscored in mouse models; Apaf-1 deficiency led to a dramatic decrease in survival following HSV-1 infection (20% survival vs. 80% in wild-type) due to uncontrolled viral replication and a blunted inflammatory response.
Conclusion and Therapeutic Potential
These findings redefine Apaf-1 as a primordial DNA sensor that predates its role in cytochrome c-mediated apoptosis. By acting as a checkpoint between two critical cellular fates, Apaf-1 represents a novel therapeutic target. Modulating the Apaf-1 DNA-binding interface could potentially be used to force tumor cells (often high in damaged DNA) back into apoptosis or to suppress runaway inflammation in autoimmune contexts.
Summary updated